Cancer Family
Basal Cell Neoplasm
CI-CAN-00000072Explore in graph →
Non-malignant58 active trials4 approved drugs6 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000072Explore in graph →
Clinical trials
362 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01367665 | STEVIE: A Study of Vismodegib in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma | completed | Phase 2 | 1,232 | Hoffmann-La RocheINDUSTRY | 37 | Jun 6, 2019 | clinicaltrials |
| NCT01700049 | Study Evaluating the Efficacy of Oral Vismodegib in Various Histologic Subtypes | completed | Phase 2 | 28 | Mayo ClinicOTHER | 1 | May 23, 2019 | clinicaltrials |
| NCT02902822 |
| Tele-dermatology of Skin Cancer in a Cohort of Local Health Authority Employees in the Province of Bergamo |
| completed |
| N/A |
| 461 |
| Centro Studi GisedOTHER |
| 1 |
| May 17, 2019 |
| clinicaltrials |
| NCT02674009 | Observational Study to Determine the Effectiveness and Safety of Vismodegib (Erivedge®) in Participants With Locally Advanced Basal Cell Carcinoma (laBCC)(NIELS) | completed | — | 67 | Hoffmann-La RocheINDUSTRY | 1 | May 13, 2019 | clinicaltrials |
| NCT02123511 | Acetylcysteine Rinse in Reducing Saliva Thickness and Mucositis in Patients With Head and Neck Cancer Undergoing Radiation Therapy | completed | Phase 2 | 34 | Mayo ClinicOTHER | 1 | Apr 30, 2019 | clinicaltrials |
| NCT02735356 | Topical Itraconazole in Treating Patients With Basal Cell Cancer | completed | Early Phase 1 | 9 | Jean Yuh TangOTHER | 1 | Apr 11, 2019 | clinicaltrials |
| NCT02296970 | An Observational Study to Determine the Clinical Cure Rate of Therapeutic up Front Shave Removal of Basal Cell Carcinoma of the Skin With Long Term Follow up to Evaluate Recurrence | completed | — | 78 | University of PittsburghOTHER | 1 | Apr 5, 2019 | clinicaltrials |
| NCT02690948 | Pembrolizumab With or Without Vismodegib in Treating Metastatic or Unresectable Basal Cell Skin Cancer | completed | Phase 1 / Phase 2 | 16 | Anne ChangOTHER | 1 | Mar 8, 2019 | clinicaltrials |
| NCT02828111 | Clinical Trial of Patidegib Gel 2%, 4%, and Vehicle Applied Once or Twice Daily to Decrease the GLI1 Biomarker in Sporadic Nodular Basal Cell Carcinomas(BCC) | completed | Phase 2 | 36 | PellePharm, Inc.INDUSTRY | 1 | Jan 8, 2019 | clinicaltrials |
| NCT01108094 | Pilot Biomarker Trial to Evaluate the Efficacy of Itraconazole in Patients w/ Basal Cell Carcinomas | completed | Phase 2 | 29 | Stanford UniversityOTHER | 1 | Nov 13, 2018 | clinicaltrials |
| NCT02668614 | Early Detection of Skin Cancer With Sensor Technology | completed | N/A | 60 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sOTHER | 0 | Nov 6, 2018 | clinicaltrials |
| NCT02270645 | Randomized Pilot Study of Treatment for BCC Using the Multiplex 595/1064 nm Laser(BCC) | completed | N/A | 12 | University of MiamiOTHER | 1 | Oct 2, 2018 | clinicaltrials |
| NCT02639117 | Photodynamic Therapy and Vismodegib for Multiple Basal Cell Carcinomas(PDT-Vismo) | completed | Phase 1 | 4 | University of ArizonaOTHER | 1 | Jul 18, 2018 | clinicaltrials |
| NCT03569345 | Basal Cell Carcinomas Treated With Ablative Fractional Laser and Ingenol Mebutate | completed | Phase 1 / Phase 2 | 20 | Merete HaedersdalOTHER | 1 | Jul 10, 2018 | clinicaltrials |
| NCT01791894 | Arsenic Trioxide in Treating Patients With Basal Cell Carcinoma(ATO) | completed | Phase 1 / Phase 2 | 5 | Stanford UniversityOTHER | 1 | Jun 8, 2018 | clinicaltrials |
| NCT02550678 | A Study of the Efficacy and Safety of ASN-002 in Adult Patients With Low-risk Nodular Basal Cell Carcinoma(ASN-002-001) | completed | Phase 1 / Phase 2 | 16 | Ascend Biopharmaceuticals LtdINDUSTRY | 1 | Jun 6, 2018 | clinicaltrials |
| NCT02007317 | Safety and Efficacy of Oshadi D and Oshadi R in Basal Cell Carcinoma Patients Prior to Tumor Excision a Phase 2 Study | completed | Phase 2 | 30 | Oshadi Drug AdministrationINDUSTRY | 1 | Apr 18, 2018 | clinicaltrials |
| NCT00601185 | Confocal Reflectance Microscopy of Shave-Biopsy Sites on Skin in Vivo. | completed | — | 116 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 27, 2018 | clinicaltrials |
| NCT02438644 | Observational Study of Vismodegib (Erivedge) in Patients Treated in Argentina | completed | — | 75 | Hoffmann-La RocheINDUSTRY | 0 | Feb 26, 2018 | clinicaltrials |
| NCT03012009 | Laser Assisted Drug Delivery in the Treatment of Superficial Non Melanoma Skin Cancer: a Randomized Controlled Trial | completed | N/A | 16 | University Hospital, GhentOTHER | 1 | Jan 25, 2018 | clinicaltrials |
| NCT01631331 | Vismodegib in Treating Patients With Basal Cell Carcinoma (BCC) | completed | Early Phase 1 | 15 | Stanford UniversityOTHER | 1 | Dec 8, 2017 | clinicaltrials |
| NCT01482104 | New Versus Approved Methyl-aminolevulinate Photodynamic Therapy (MAL-PDT) Regime in Basal Cell Carcinoma (BCC) | completed | N/A | 277 | Norwegian University of Science and TechnologyOTHER | 1 | Oct 27, 2017 | clinicaltrials |
| NCT01815840 | A Study of Two Vismodegib Regimens in Participants With Multiple Basal Cell Carcinomas | completed | Phase 2 | 229 | Hoffmann-La RocheINDUSTRY | 10 | Sep 28, 2017 | clinicaltrials |
| NCT02409628 | EktoTherix™ Regenerative Tissue Scaffold for Repair of Surgical Excision Wounds | completed | N/A | 12 | Neotherix LimitedINDUSTRY | 1 | Sep 15, 2017 | clinicaltrials |
| NCT02100111 | An Analysis of Treatment Patterns and Outcomes for Basal Cell Carcinoma (BCC) Cancer Participants | completed | — | 134 | Hoffmann-La RocheINDUSTRY | 4 | Jul 24, 2017 | clinicaltrials |
| NCT01773447 | Set-back Suture Versus Traditional Vertical Mattress Suture | completed | N/A | 47 | University of California, DavisOTHER | 1 | Mar 31, 2017 | clinicaltrials |
| NCT00218829 | DMSO-PDT of BCC - A 6 Year Follow up | completed | — | 44 | Norwegian University of Science and TechnologyOTHER | 0 | Mar 14, 2017 | clinicaltrials |
| NCT01529450 | Pilot LDE225 in Locally Advanced or Metastatic BCC + Previously Tx Non-LDE225 Smoothened Inhibitors | completed | N/A | 11 | Anne ChangOTHER | 1 | Jan 16, 2017 | clinicaltrials |
| NCT02939027 | Study of Electronic Brachytherapy for Cutaneous Basal Cell Carcinoma | completed | N/A | 40 | Instituto de Investigacion Sanitaria La FeOTHER | 0 | Oct 19, 2016 | clinicaltrials |
| NCT00237107 | Debulking Effect of Curretage on Basal Cell Carcinomas - a Histological Assessment. | completed | N/A | 36 | Norwegian University of Science and TechnologyOTHER | 0 | Jul 19, 2016 | clinicaltrials |
| NCT00003611 | Acitretin in Preventing Skin Cancers in Patients With Previously Treated Skin Cancers Who Have Undergone Organ Transplantation | completed | N/A | 129 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jul 13, 2016 | clinicaltrials |
| NCT02029352 | Topical Green Tea Ointment in Treatment of Superficial Skin Cancer | completed | Phase 2 / Phase 3 | 42 | Maastricht University Medical CenterOTHER | 1 | May 18, 2016 | clinicaltrials |
| NCT02285790 | One-stop-shop Study for Treatment of Basal Cell Carcinoma Using Reflectance Confocal Microscopy(B-OSS) | completed | N/A | 100 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 | Apr 13, 2016 | clinicaltrials |
| NCT01325688 | PEP005 Gel - Evaluation of the Safety and Efficacy of Ingenol Mebutate Gel on a Superficial Basal Cell Carcinoma on the Trunk or Extremities | completed | Phase 2 | 75 | PeplinINDUSTRY | 1 | Feb 26, 2016 | clinicaltrials |
| NCT00432185 | To Determine the Maximum Tolerated Dose Level (MTD) of PEP005 Topical Gel in Patients With sBCC | completed | Phase 2 | 117 | PeplinINDUSTRY | 1 | Feb 15, 2016 | clinicaltrials |
| NCT00574392 | Multi-Wavelength and Coherence Confocal Reflectance Microscopy of Pigmented and Non-Pigmented Lesions on the Skin In-Vivo | completed | — | 50 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 18, 2015 | clinicaltrials |
| NCT00089180 | T4N5 Liposomal Lotion in Preventing The Recurrence of Nonmelanoma Skin Cancer in Patients Who Have Undergone a Kidney Transplant | completed | Phase 2 | 100 | National Cancer Institute (NCI)NIH | 1 | Dec 4, 2015 | clinicaltrials |
| NCT01350115 | Efficacy, Safety and Pharmacokinetics of Oral LDE225 in Treatment of Patients With Nevoid Basal Cell Carcinoma Syndrome (NBCCS) | completed | Phase 2 | 10 | Novartis PharmaceuticalsINDUSTRY | 4 | Oct 19, 2015 | clinicaltrials |
| NCT00397384 | Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer | completed | Phase 1 | 43 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2015 | clinicaltrials |
| NCT02158650 | Video-Based Treatment Options for Basal Cell Carcinoma | completed | N/A | 32 | Emory UniversityOTHER | 1 | Aug 17, 2015 | clinicaltrials |
| NCT01260987 | Fractional CO2 Laser Assisted Photodynamic Therapy | completed | Phase 2 / Phase 3 | 47 | Bispebjerg HospitalOTHER | 1 | Jul 30, 2015 | clinicaltrials |
| NCT01770002 | Eversion in Dermatologic Surgery: Is Cosmetic Appearance Improved? | completed | N/A | 50 | University of California, DavisOTHER | 1 | Apr 16, 2015 | clinicaltrials |
| NCT00108121 | Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Nodular Basal Cell Carcinoma | completed | Phase 2 | 60 | PeplinINDUSTRY | 1 | Jan 19, 2015 | clinicaltrials |
| NCT01358045 | Topical Vitamin D3, Diclofenac or a Combination of Both to Treat Basal Cell Carcinoma | completed | Phase 2 | 128 | Maastricht University Medical CenterOTHER | 1 | Jan 13, 2015 | clinicaltrials |
| NCT01292668 | Photodynamic Therapy Using Methyl-5-Aminolevulinate Hydrochloride Cream in Determining Pain Threshold in Patients With Skin Cancer | completed | Phase 1 | 21 | Roswell Park Cancer InstituteOTHER | 1 | Sep 29, 2014 | clinicaltrials |
| NCT01543581 | Vismodegib for Treatment of Basal Cell Carcinoma(Erivedge) | completed | Phase 2 | 3 | Abel Torres, MDOTHER | 0 | Sep 26, 2014 | clinicaltrials |
| NCT00670189 | A Phase 1 Study of BMS-833923 (XL139) in Subjects With Advanced or Metastatic Cancer | completed | Phase 1 | 53 | Bristol-Myers SquibbINDUSTRY | 2 | Aug 15, 2014 | clinicaltrials |
| NCT00374062 | Effect of the Subconscious on Mohs Micrographic Surgery | completed | N/A | 150 | Northwestern UniversityOTHER | 1 | Jul 15, 2014 | clinicaltrials |
| NCT01201915 | A Study Evaluating the Efficacy and Safety of Vismodegib (GDC-0449) in Operable Basal Cell Carcinoma | completed | Phase 2 | 74 | Genentech, Inc.INDUSTRY | 1 | Jun 24, 2014 | clinicaltrials |
| NCT00101348 | Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 66 | National Cancer Institute (NCI)NIH | 1 | Jun 11, 2014 | clinicaltrials |
Data updated 22 days agoSource updated Jun 6, 2019source: clinicaltrials